-
981
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
Published 2022-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
982
GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma
Published 2021-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
983
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
984
Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism?
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
985
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
986
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
987
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
988
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
989
Correction: Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
990
Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
991
Weal and woe of interleukin-18 in the T cell therapy of cancer
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
992
Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
993
Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
994
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
995
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
996
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies
Published 2024-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
997
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
Published 2021-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
998
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
999
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
1000
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article